Schizophrenia presents in a variety of ways and leads to a variety of outcomes. Of relevance to this heterogeneity is the overlapping boundary between schizophrenia and affective disorder. Some schizophrenic patients manifest symptomatology and natural course similar to affective disorders. There is some evidence for an excess of affective disorder among the relatives of schizophrenic patients. Rapid eye movement (REM) sleep latency, considered to be a consistent biological marker for affective disorder, is also seen in some patients with schizophrenia. In this study, it is hypothesized that schizophrenic patients with shortened REM latency will have more frequent family histories of affective disorders as well as a more favorable therapeutic response to lithium and neuroleptics, a recurrent course, and less residual symptomatology between episodes. Polysomnographic studies will be performed in consecutive drug-free patients with DSM-III-R schizophrenia and schizophreniform disorders. The family study method to ascertain psychiatric morbidity in first degrees relatives will be used. Patients will be longitudinally evaluated with psychopathological ratings weekly during the initial treatment with lithium (2 weeks) and neuroleptics (4 weeks) and then periodically up to 2 years during standard neuroleptic maintenance treatment. The psychiatric morbidity among the family members of the subgroups of these patients with and without shortened REM latency will be compared. The therapeutic response to lithium and neuroleptics and the course of the disorder in these groups will also be compared. The relationships between other sleep parameters (e.g., REM density, NON-REM sleep) family history and outcome measures, will also be explored.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH045203-04
Application #
2246464
Study Section
Psychopathology and Clinical Biology Research Review Committee (PCB)
Project Start
1991-04-01
Project End
1996-03-31
Budget Start
1994-04-01
Budget End
1996-03-31
Support Year
4
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Psychiatry
Type
Schools of Medicine
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Francis, Alan N; Bhojraj, Tejas S; Prasad, Konasale M et al. (2013) Alterations in the cerebral white matter of genetic high risk offspring of patients with schizophrenia spectrum disorder. Prog Neuropsychopharmacol Biol Psychiatry 40:187-92
Yao, Jeffrey K; Condray, Ruth; Dougherty Jr, George G et al. (2012) Associations between purine metabolites and clinical symptoms in schizophrenia. PLoS One 7:e42165
Yao, Jeffrey K; Keshavan, Matcheri S (2011) Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view. Antioxid Redox Signal 15:2011-35
Keshavan, Matcheri S; Montrose, Debra M; Miewald, Jean M et al. (2011) Sleep correlates of cognition in early course psychotic disorders. Schizophr Res 131:231-4
Condray, Ruth; Dougherty Jr, George G; Keshavan, Matcheri S et al. (2011) 3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia. Int J Neuropsychopharmacol 14:756-67
Francis, Alan N; Bhojraj, Tejas S; Prasad, Konasale M et al. (2011) Abnormalities of the corpus callosum in non-psychotic high-risk offspring of schizophrenia patients. Psychiatry Res 191:9-15
Reddy, R; Fleet-Michaliszyn, S; Condray, R et al. (2011) Reduction in perseverative errors with adjunctive ethyl-eicosapentaenoic acid in patients with schizophrenia: Preliminary study. Prostaglandins Leukot Essent Fatty Acids 84:79-83
Diwadkar, Vaibhav A; Goradia, Dhruman; Hosanagar, Avinash et al. (2011) Working memory and attention deficits in adolescent offspring of schizophrenia or bipolar patients: comparing vulnerability markers. Prog Neuropsychopharmacol Biol Psychiatry 35:1349-54
Yao, Jeffrey K; Dougherty Jr, George G; Reddy, Ravinder D et al. (2010) Homeostatic imbalance of purine catabolism in first-episode neuroleptic-naive patients with schizophrenia. PLoS One 5:e9508
Yao, J K; Dougherty Jr, G G; Reddy, R D et al. (2010) Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia. Mol Psychiatry 15:938-53

Showing the most recent 10 out of 53 publications